| Breakdown | Dec 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 120.50M | 137.08M | 119.63M | 199.72M | 195.28M |
| Gross Profit | 37.99M | 65.07M | 42.00M | 115.66M | 99.65M |
| EBITDA | 38.64M | 143.38M | 973.69M | 76.21M | 101.97M |
| Net Income | -218.18M | -26.58M | 831.66M | -116.44M | -26.12M |
Balance Sheet | |||||
| Total Assets | 501.95M | 606.00M | 519.34M | 590.12M | 565.31M |
| Cash, Cash Equivalents and Short-Term Investments | 143.34M | 150.42M | 161.71M | 233.58M | 165.25M |
| Total Debt | 705.82M | 571.37M | 471.75M | 1.40B | 1.29B |
| Total Liabilities | 808.82M | 698.48M | 585.01M | 1.53B | 1.39B |
| Stockholders Equity | -306.39M | -92.54M | -66.17M | -940.23M | -823.25M |
Cash Flow | |||||
| Free Cash Flow | -3.80M | 535.00K | -19.48M | 87.43M | 108.58M |
| Operating Cash Flow | 19.59M | 33.08M | -2.22M | 102.20M | 117.42M |
| Investing Cash Flow | -23.39M | -26.47M | -28.08M | -15.78M | -19.78M |
| Financing Cash Flow | -2.78M | -17.71M | -41.62M | -17.48M | -10.86M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% | |
52 Neutral | £9.89M | -4.18 | -14.83% | ― | ― | ― | |
51 Neutral | £5.77M | -0.02 | 42.95% | ― | -16.37% | -701.89% | |
47 Neutral | £14.43M | -1.04 | -7.46% | ― | ― | 47.17% | |
| ― | £5.33M | 5.86 | -13.06% | 55.43% | 140.95% | 63.64% | |
51 Neutral | £11.80M | -3.85 | -4.96% | ― | -13.57% | 35.00% |